Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Checkpoint Therapeutics, Inc.

NASDAQ: CKPTHealthcare / Biotechnology / -
2.95-0.4100-12.20%Vol 76 7181Y Perf -33.56%
Feb 21st, 2019 16:00
BID2.95 ASK3.03
Open3.35 Previous Close3.36
Pre-Market- After-Trading-
 - -%  - -%
Target Price
15.50 
Analyst Rating
Strong Buy 1.00
Potencial %
425.42 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)100 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
30.27 
Earnings Date
15th Mar 2019

Today's Price Range

2.873.38

 

52wk Range

1.506.29

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-7.81%
3 Months
33.48%
6 Months
-30.42%
1 Year
-33.56%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CKPT2.95-0.4100-12.20
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.40
Current Ratio
3.50
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-3 802.90
EBITDA Margin
-3 802.90
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
5.89
PS Ratios
268.79
Price to Cash Flow
-
Price to Free Cash Flow
-7.10
Cash Flow Per Share
-0.85
Price to Tangible Book
5.89
Book Value per Share
0.65
Enterprise Value (in ths.)
100 117
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-146.60
Return on Assets (5Y Avg)
-
ROA last 12 Months
-108.63
Return on Capital (5Y Avg)
-
ROC last 12 Months
-147.18
Return on invested Capital Q
-42.36
Return on invested Capital Y
-96.21
Assets Turnover
0.00
Receivables Turnover
0.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
475
Revenue per Share
0.01
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.22-0.32-45.45
Q02 2018-0.35-0.2334.29
Q01 2018-0.19-0.35-84.21
Q04 2017-0.27-0.263.70
Q02 2017--0.28-
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.250.00-
12/2018 QR-0.2233.33Positive
12/2018 FY-1.200.00-
12/2019 FY-1.150.00-
Next Report Date15th Mar 2019
Estimated EPS Next Report-0.25
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume76 718
Shares Outstanding (in ths.)34 046
Trades Count197
Dollar Volume216 933
Avg. Volume52 135
Avg. Weekly Volume43 022
Avg. Monthly Volume46 221
Avg. Quarterly Volume67 775

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

53%47%

Bearish Bullish

33%67%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News